GSK plc

Update in progress

GSK (NYSE)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - General

GSK plc, with its subsidiaries, discovers, develops, and manufactures vaccines, specialty medicines, and general medicines to prevent and treat disease worldwide. It operates through Commercial Operations and Total R&D, offering oncology, respiratory/immunology, inflammation, HIV, and other therapies, plus a broad vaccine portfolio. It collaborates with CureVac on mRNA vaccines and with AN2 Therapeutics on TB. Founded in 1715, headquartered in London.

Company score

Sentiment: 2.48; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.32; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 2.39; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.69; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.97; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 1.73; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive